These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

280 related items for PubMed ID: 9701250

  • 1. Restoration of cytomegalovirus-specific CD4+ T-lymphocyte responses after ganciclovir and highly active antiretroviral therapy in individuals infected with HIV-1.
    Komanduri KV, Viswanathan MN, Wieder ED, Schmidt DK, Bredt BM, Jacobson MA, McCune JM.
    Nat Med; 1998 Aug; 4(8):953-6. PubMed ID: 9701250
    [Abstract] [Full Text] [Related]

  • 2. High-dose (5000-microg) intravitreal ganciclovir combined with highly active antiretroviral therapy for cytomegalovirus retinitis in HIV-infected patients in Venezuela.
    Arevalo JF, Garcia RA, Mendoza AJ.
    Eur J Ophthalmol; 2005 Aug; 15(5):610-8. PubMed ID: 16167292
    [Abstract] [Full Text] [Related]

  • 3. Cytomegalovirus retinitis after initiation of highly active antiretroviral therapy in HIV infected patients: natural history and clinical predictors.
    Lin DY, Warren JF, Lazzeroni LC, Wolitz RA, Mansour SE.
    Retina; 2002 Jun; 22(3):268-77. PubMed ID: 12055458
    [Abstract] [Full Text] [Related]

  • 4. Multiple relapses of human cytomegalovirus retinitis during HAART in an AIDS patient with reconstitution of CD4+ T cell count in the absence of HCMV-specific CD4+ T cell response.
    Lilleri D, Piccinini G, Baldanti F, Seminari E, Galloni D, Gerna G.
    J Clin Virol; 2003 Jan; 26(1):95-100. PubMed ID: 12589839
    [Abstract] [Full Text] [Related]

  • 5. Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis.
    Macdonald JC, Karavellas MP, Torriani FJ, Morse LS, Smith IL, Reed JB, Freeman WR.
    Ophthalmology; 2000 May; 107(5):877-81; discussion 881-3. PubMed ID: 10811078
    [Abstract] [Full Text] [Related]

  • 6. Loss of cytomegalovirus-specific CD4+ T cell responses in human immunodeficiency virus type 1-infected patients with high CD4+ T cell counts and recurrent retinitis.
    Komanduri KV, Feinberg J, Hutchins RK, Frame RD, Schmidt DK, Viswanathan MN, Lalezari JP, McCune JM.
    J Infect Dis; 2001 Apr 15; 183(8):1285-9. PubMed ID: 11262214
    [Abstract] [Full Text] [Related]

  • 7. Cytomegalovirus (CMV)-specific CD4+ T lymphocyte immune function in long-term survivors of AIDS-related CMV end-organ disease who are receiving potent antiretroviral therapy.
    Jacobson MA, Schrier R, McCune JM, Torriani FJ, Holland GN, O'Donnell JJ, Freeman WR, Bredt BM.
    J Infect Dis; 2001 May 01; 183(9):1399-404. PubMed ID: 11294673
    [Abstract] [Full Text] [Related]

  • 8. Characterization of reactivation of cytomegalovirus retinitis in patients healed after treatment with highly active antiretroviral therapy.
    Song MK, Karavellas MP, MacDonald JC, Plummer DJ, Freeman WR.
    Retina; 2000 May 01; 20(2):151-5. PubMed ID: 10783947
    [Abstract] [Full Text] [Related]

  • 9. Dynamics of cytomegalovirus (CMV)-specific T cells in HIV-1-infected individuals progressing to AIDS with CMV end-organ disease.
    Bronke C, Palmer NM, Jansen CA, Westerlaken GH, Polstra AM, Reiss P, Bakker M, Miedema F, Tesselaar K, van Baarle D.
    J Infect Dis; 2005 Mar 15; 191(6):873-80. PubMed ID: 15717261
    [Abstract] [Full Text] [Related]

  • 10. Characteristics of untreated AIDS-related cytomegalovirus retinitis. II. Findings in the era of highly active antiretroviral therapy (1997 to 2000).
    Holland GN, Vaudaux JD, Shiramizu KM, Yu F, Goldenberg DT, Gupta A, Carlson M, Read RW, Novack RD, Kuppermann BD, Southern California HIV/Eye Consortium.
    Am J Ophthalmol; 2008 Jan 15; 145(1):12-22. PubMed ID: 18154751
    [Abstract] [Full Text] [Related]

  • 11. Highly active antiretroviral therapy-associated regression of cytomegalovirus retinitis: long-Term results in a small case series.
    Reed JB, Briggs JW, McDonald JC, Freeman WR, Morse LS.
    Retina; 2001 Jan 15; 21(4):339-43. PubMed ID: 11508879
    [Abstract] [Full Text] [Related]

  • 12. Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy.
    Macdonald JC, Torriani FJ, Morse LS, Karavellas MP, Reed JB, Freeman WR.
    J Infect Dis; 1998 May 15; 177(5):1182-7. PubMed ID: 9593001
    [Abstract] [Full Text] [Related]

  • 13. Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: 1. Retinitis progression.
    Jabs DA, Van Natta ML, Thorne JE, Weinberg DV, Meredith TA, Kuppermann BD, Sepkowitz K, Li HK, Studies of Ocular Complications of AIDS Research Group.
    Ophthalmology; 2004 Dec 15; 111(12):2224-31. PubMed ID: 15582078
    [Abstract] [Full Text] [Related]

  • 14. Discontinuation of maintenance therapy in patients with quiescent cytomegalovirus retinitis and elevated CD4+ counts.
    Vrabec TR, Baldassano VF, Whitcup SM.
    Ophthalmology; 1998 Jul 15; 105(7):1259-64. PubMed ID: 9663231
    [Abstract] [Full Text] [Related]

  • 15. Paradoxical activity of CMV retinitis in patients receiving highly active antiretroviral therapy.
    Song MK, Schrier RD, Smith IL, Plummer DJ, Freeman WR.
    Retina; 2002 Jun 15; 22(3):262-7. PubMed ID: 12055457
    [Abstract] [Full Text] [Related]

  • 16. Occurrence of cytomegalovirus retinitis after human immunodeficiency virus immunosuppression.
    Hoover DR, Peng Y, Saah A, Semba R, Detels RR, Rinaldo CR, Phair JP.
    Arch Ophthalmol; 1996 Jul 15; 114(7):821-7. PubMed ID: 8660165
    [Abstract] [Full Text] [Related]

  • 17. Nonprogressive CMV retinitis in AIDS patients with protease inhibitors therapy for AIDS.
    Ortega-Larrocea G, Feregrino-Goyos M.
    Ocul Immunol Inflamm; 1997 Dec 15; 5(4):279-82. PubMed ID: 9455745
    [Abstract] [Full Text] [Related]

  • 18. Discontinuation of anticytomegalovirus therapy in patients with HIV infection and cytomegalovirus retinitis.
    Whitcup SM, Fortin E, Lindblad AS, Griffiths P, Metcalf JA, Robinson MR, Manischewitz J, Baird B, Perry C, Kidd IM, Vrabec T, Davey RT, Falloon J, Walker RE, Kovacs JA, Lane HC, Nussenblatt RB, Smith J, Masur H, Polis MA.
    JAMA; 1999 Nov 03; 282(17):1633-7. PubMed ID: 10553789
    [Abstract] [Full Text] [Related]

  • 19. Sustained cytomegalovirus-specific CD4+ T cell response associated with prevention of recurrence of cytomegalovirus retinitis without secondary prophylaxis after highly active antiretroviral therapy in patients with AIDS.
    Tanaka M, Yasuoka C, Genka I, Tachikawa N, Kikuchi Y, Teruya K, Yasuoka A, Hirabayashi Y, Kimura S, Oka S.
    AIDS Res Hum Retroviruses; 2001 Dec 10; 17(18):1749-56. PubMed ID: 11788026
    [Abstract] [Full Text] [Related]

  • 20. Restoration of CD4 T-cell responses to cytomegalovirus is short-lived in severely immunodeficient HIV-infected patients responding to highly active antiretroviral therapy.
    Keane NM, Price P, Lee S, Almeida CA, Stone SF, James I, French MA.
    HIV Med; 2004 Nov 10; 5(6):407-14. PubMed ID: 15544692
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.